Biosimilars [Design Issues]

posted by drgunasakaran1  – 2012-02-10 12:33 (5235 d 12:15 ago) – Posting: # 8094
Views: 8,613

❝ As far as FDA is concerned i am not able to find specific guideline for biosimiler.


Dear Mr.Chiku,

The U.S. Food and Drug Administration issued three draft guidance documents on biosimilar product development to assist industry in developing such products in the United States.

Scientific Considerations in Demonstrating Biosimilarity to a Reference Product

Quality Considerations in Demonstrating Biosimilarity to a Reference Protein Product

Biosimilars: Q & A - Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
114 visitors (0 registered, 114 guests [including 18 identified bots]).
Forum time: 01:48 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5